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INTRODUCTION 
Delezene  and  Pozerski  in  1903 reported  that  serum  becomes proteolytic when 
shaken  with chloroform.  This observation  has been  repeatedly  confirmed by sub- 
sequent investigators.  It has  also been  shown  that a  variety of other agents  and 
procedures  will release  the proteolytic activity of serum  (Opie and  Barker,  1907, 
1908; Yamakawa, 1918; Pope, 1938; Juhling and W~hlish, 1938).  It has been pos- 
tulated  by  some  investigators  (Delezene  and  Pozerski,  1903; Yamakawa,  1918; 
Sehmitz,  1937, Iyengar, 1942)  that the  proteolytic activity is held  in  check by a 
protease  inhibitor  also  present  in  serum,  and  that  activation or liberation  of the 
protease occurs when the inhibitor is removed. 
The recent demonstration  (Christensen,  1945; Christensen  and  MacLeod,  1945) 
that the protease  of serum is present as a zymogen (plasminogen) which is catalyti- 
cally converted to the active enzyme (plasmin)  by the action of a bacterial  klnase 
(streptokinase)  led to a study of the mechanism of activation by chloroform, since it 
had  also  been  shown  that  the  chloroform-activated  protease  and plasmin  are  ap- 
parently identical  (Christensen  and MacLeod,  1945).  At least two mechanisms can 
be  suggested  to  explain  chloroform  activation.  Chloroform  may  exert  a  direct 
catalytic influence on the plasminogen,  •  "  converting it to plasmin,  or chloroform may 
react with some other component of serum and exert its effect in an indirect manner, 
either by removing inhibitor  and allowing spontaneous  activation of the protease~ or 
by altering  some substance  in  serum  which  in  turn  reacts  with  the plasminogen. 
In order to determine  which, if either,  of the  above postulates is correct, 
samples of serum were activated by treatment with chloroform and the develop- 
ment  of  spontaneous  activity,  the  level  of  total  activity,  and  the  level  of 
inhibitor were measured. 
Methods  and  Martials 
1. Total Proteolytic Acti~ity of Serum.--The method is based  on the earlier  obser- 
vation that the plasminogen of serum or its globulin fraction is quantitatively con- 
vetted to plasmin almost instantaneously in the presence of an excess of streptokinase 
(Christensen,  1945; Christensen  and MacLeod,  1945).  The plasminogen  is quanti- 
tatively precipitated from serum by the addition  of 2 volumes of 0.5 saturated am- 
monium  sulfate.  To determine  plasminogen,  2.5 ml.  of serum  are mixed with 5.0 
* This study was supported  in part by the Ralph B. Rogers Rheumatic Fever Fund. 
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ml. of 0.5 saturated ammonium sulfate and the precipitate collected by centrifugation 
in a conical graduated tube.  The supernatant is decanted and the precipitate made 
up to 1.0 ml. with saline buffer.  This concentration procedure serves two purposes. 
The inhibitor is found largely in the albumin fraction of serum (Landsteiner,  1900; 
Grob, 1943), thus the separation and discarding of this fraction minimizes the effect 
of serum  inhibitor on the  determination.  Secondly, the two  and  a  half-fold con- 
centration of the proteolytic activity results in more accurate determinations with the 
test system used.  For activation of the plasminogen, 1.0 ml. of the serum fraction 
solution is mixed with 0.1 ml. of a  1:10 dilution of a  streptokinase concentrate and 
incubated for about  1 minute at 35°C.  The plasmin mixture is then added to 6.0 
ml. of 5 per cent gelatin solution, poured into a viscosimeter, and the rate of decrease 
in specific viscosity at 35°C. determined as outlined in a previous report (Christensen 
and  MacLeod,  1945).  Both  the  enzyme and  substrate  solutions,  as  well  as  the 
viscosimeter are warmed to 35°C. before using.  By definition, 1 plasmin unit is that 
amount of phismin which will cause a  fall of 1 per cent per minute in the specific 
viscosity of the standard enzyme-substrate mixture.  Prdiminary experiments with 
the lot of streptokinase employed had established the concentration to be used in order 
to produce maximum activation of the protease. 
2. Spontaneous Proteolylic Activity of Serum.--Spontaneous activity determinations 
were made in the same manner as the determinations of total activity with the ex- 
ception that buffer was substituted for streptokinase solution. 
3. Serum Teypsin Inhib~or.--The available evidence (Schmitz, 1938; Grob, 1943; 
Christensen and MacLeod, 1945) indicates that there is present in serum a protease 
inhibitor identical with, or very. similar to, the crystalline inhibitor isolated by Kunitz 
and Northrop (1936) from the pancreas.  The method of inhibitor titration adopted, 
therefore, is a modification of one recently devised by Kunitz  t (1945) for the titration 
of pancreatic and soy bean inhibitors.  ~The inhibitory power of the serum sample is 
expressed in terms of the amount of a standard preparation of crystalline pancreatic 
trypsin inhibitor necessary to produce the same degree of inhibition of a  standard 
preparation of crystalline trypsin. 
The determination is carried out as follows: 0.5 ml. of a solution of crystalline tryp- 
sin, containing 0.1 rag., is mixed with 0.5 ral. of appropriate dilutions of the inhibitor 
solution at pH 7.6.  The mixture is incubated at 35°C. for 15 minutes to allow combi- 
nation of the inhibitor and enzyme.  At the end of this time, 1.0 ml. of the warmed 
substrate, 5 per cent casein in 10 per cent urea, is added and mixed.  The mixtures 
are incubated for exactly 5 minutes, when the reaction is stopped by the addition of 3.0 
ml. of 5 per cent trichloracetic acid.  The tubes are shaken and allowed to stand for 
10 to 15 minutes, then filtered  to remove the precipitated protein.  The extent  of 
proteolysis  is  measured  by  determining  the  amount  of  acid-soluble  chromogenic 
material in the filtrates by the copper-phenol method of Herriott (1941)  as modified 
by Heidelberger and MacPherson (1943).  For convenience, the results are expressed 
in terms of the amount of crystalline tyrosine necessary to produce the same amount 
of color under the same conditions, although the color in the filtrates is due to other 
1 We are  very grateful  to  Dr.  M.  Kunitz for suggestions and  advice regarding 
methods of inhibitor titration in advance of publication of his method, and for generous 
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substances  in  addition  to  the  tryosine.  Under  these  conditions,  the  amount  of 
chromogenic material is a linear function of the concentration of free trypsin (Fig. 1), 
indicating that the amount of protcolysis is directly proportional to the free enzyme 
concentration. 
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FIG.  I. The  relation  between  the  concentration  of cryst~|llne  trypsin  and  the 
amount of acid-soluble "tryosine" liberated from urea-casein. 
A calibration curve was prepared by adding varying amounts of the standard crys- 
talline pancreatic trypsin inhibitor in a  volume of 0.5 ml.  to constant amounts of 
crystalline trypsin in 0.5 ml., incubating at pH 7.6, and reacting with substrate as 
described above.  When the color values obtained in such an experiment are plotted, 
it is seen that the values fall along a sigmoid curve (Fig. 2).  Since it has been shown 
(Hussey and  Northrop,  1922-23;  Grob,  1943)  that  trypsin  and  inhibitor  form a 
stoichiometric, reversible combination in accordance with the law of mass action, it is 
to be expected that the amounts of free or dissociated trypsin will fall along the familiar 
buffer type curve.  Because the inhibition curve is sigmoid, the comparison point of 
the inhibitor  titration  is  taken as that amount of inhibitor producing 50 per cent 
inhibition of the trypsin solution, since in this region the slopes of the curves to be 152  CHLOROFORM"  ACTIVATION  OF  PLASMINOGEN 
compared are maximal and consequently the results will be least affected by experi- 
mental errors.  The method is applicable over a fairly wide range of trypsin levels, 
since, as may be seen in Fig. 3, there is a linear relationship between the amount of 
trypsin used and the amount of inhibitor necessary to produce 50 per cent inhibition. 
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FIG. 2.  Inhibition of crystalline trypsin by crystalline pancreatic trypsin inhibitor 
Increasing amounts of inhibitor were added to a  constant amount of trypsin.  The 
acid-soluble "tryosine" is a  measure of the active or uncombined trypsin. 
In the present study the amount of trypsin used liberates acid-soluble chromogenic 
material equivalent to 50 to 60 micrograms of tryosine under the conditions described. 
In titrating the inhibitor levels of sera, it has been found that the majority of 
normal sera will give values within the workable range if 0.5, 0.4, 0.3, 0.2, and 0.1 
ml. of a 1:50 ml. dilution, in pH 7.6 buffer made up to a volume of 0.5 ml., are added 
to the standard trypsin solution.  The color values of the filtrates are plotted, and by 
interpolation, the quantity of serum necessary to produce 50 per cent inhibition is 
determined.  By reference to the calibration curve the quantity of standard inhibitor 
necessary to produce 50 per cent inhibition of the trypsin solution can be found, and 
the inhibitory power of the serum can then  be expressed in terms of milligrams of the 
standard per milliliter  of serum. r..  R.  c~v~sTsssn.};  155 
4.  Casein-Urea Substrate.--$ gin. of Borden's casein No. 453 are mixed with 10 gin. 
urea and dissolved in ~line buffer.  The final pH is adjusted to pH 7.8 to 8.0 and the 
volume made up to I00 ml.  It has been found advantageous to add the urea in order 
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FzG. 3.  The relation between the concentration of trypsin and the concentration of 
crystalline pancreatic trypsin inhibitor necessary to produce 50 per cent inhibition. 
to insure rapid and complete solution of the casein.  Apparently the addition of urea 
does not alter the course of either the inhibition or proteolysis, since comparable results 
were obtained when casein without urea was used.  It has been found that the blank 
color values of urea-casein and casein solutions rise rather rapidly as the casein solu- 
tions stand, and it appears that some of this color arises at the expense of the chro- 
mogenic material liberated by trypsin action.  For this reason solutions  should be 
prepared immediatdy before use.  Other samples of casein are satisfactory as  sub- 
stmtes, so long as they do not give blank values which are too high. 
5. Standard  Trypsin.--A sampIe of crystalline material purchased from the Plaut 
Research Laboratories was used.  The material contained about 85 per cent mag- 154  CHLOROFORM  ACTIVATION  OF  PLASMINOGEN 
nesium  sulfate.  A  stock solution  containing  2.0  mg./ml.was  prepared in 0.05 N 
HCI.  This Stock solUtion was  stable for several  weeks.  This stock solution  was 
diluted 1:10 with saline buffer pH 7.6 immediately before use.  :As mentioned above, 
0.5 ml. of this diluted solution, under the conditions  of the test, liberates ehromogenic 
material equivalent to about 50 micrograms of tyrosine. 
6.  Standard  Trypsin Inhibitor.--A  sample  of crystalline pancreatic inhibitor was 
kindly supplied by Dr. Kunitz.l  It contained about 50 per cent magnesium sulfate. 
The total S was 0.089 mg. per rag. dry weight of the material.  A stock solution con- 
taining 1 mg./ml, was made up in distilled water.  This solution is also quite stable. 
Decreasing quantities, beginning with about 20 micrograms, in 0.5 ml. were made up 
in saline buffer pH 7.6 immediately before use in preparing the calibration curves. 
7.  The preparation of saline buffer, gelatin solutions for viscosity determinations, 
and other materials used has been described in previous reports (Christensen,  1945; 
Christensen and MacLeod, 1945). 
EXPERIMENTAL 
It was felt that pertinent information regarding the mechanism of chloroform 
activation would be the rate and magnitude of the decrease in serum inhibitor 
and the  rate  and magnitude of the  increase in spontaneous activity of the 
chloroform-treated serum.  Accordingly, 100 ml. of fresh human serum were 
shaken with 10 ml. of chloroform for 2 minutes.  At the end of this period an 
aliquot was removed and as much insoluble material and chloroform as possible 
sedimented from it by centrifugation in a  Swedish angle centrifuge at about 
5000 R.p.~r.  This aliquot was titrated for inhibitor, spontaneous activity, and 
total  activity by the  methods  outlined  above.  These determinations were 
repeated at intervals on successive aliquots of the chloroform-treated serum. 
Initial  values  for this  serum  were  obtained on  a  portion not  treated  with 
chloroform.  The results of this experiment ~re plotted in Fig. 4. 
It can be seen from Fig. 4 that immediately following treatoent with chloro- 
form the inhibitor concentration of the serum dropped to less than 10 per cent 
of  the  original  value.  The  total  protease  activity  of the  serum  was  also 
diminished  immediately  following  chloroform  treatment,  probably  due  to 
denaturation of a portion of the enzyme, since it can be shown that continued 
shaking with chloroform eventually destroys most if not all protease activity. 
However, the most significant fact shown by this experiment is the long delay 
in  the  appearance of spontaneous activity in  the  treated serum.  Further, 
the course of the activation of this protease is not that of a first order reaction, 
as is the activation of plasminogen by streptokinase.  Rather, the curve sug- 
gests an autocatalytic type of reaction.  On further analysis, it can be seen 
that the curve also deviates from that characteristic of an autocatalytic re- 
action in that  there is less activity in the later stages of the  reaction than 
expected.  A possible explanation of this deviation may lie in the fact that in 
the presence of active plasmin, either plasmin, plasminogen, or both are quite L.  R.  CHRISTENSEN  155 
unstable.  It will be noted in Fig. 4  that  the total protease activity of the 
treated  serum  begins to fall off at about the time spontaneous activity of 
the preparation becomes appreciable, suggesting digestion of one or both forms 
of the enzyme.  Other experiments in this and other laboratories (EdsaU, 1946) 
have  confirmed this  loss  of proteolytic activity in  preparations  which  are 
partially or wholly activated.  On the other hand, plasminogen preparations 
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FiG.  4.  The  development of proteolytic activity  in  chloroform-treated serum. 
The total protease actiVity was determined by adding an excess of streptokinase to the 
treated  serum.  Spontaneously activated  protease  was  determined  without  the; 
addition of streptokinase.  Inhibitor is expressed as the amount of crystalline pan, 
creatic inhibitor necessary to produce the same amount of inhibition  of the standard: 
trypsin solution as produced by the serum. 
with  little  or no spontaneous activity do not show a  loss of streptokinase  7 
activatable  activity when  stored  for  weeks  or  months  (Christensen,  1945; 
Christensen and MacLeod, 1945). 
This  experiment has  been  repeated  on  several  specimens  of human and 
animal serum.  The human sera tested all behaved in the same manner, that is, 
a rapid drop in the level of "inhibitor, followed by an acceleratingrate of spon- 
taneous  activation,  together with  a  drop  in  total  activity.  Activation by 
chloroform in no instance resulted in liberation of more than half of the total 156  CHLOROI~ORM  ACTIVATION  O~'  PLASMINOGEN 
proteolytic activity of the serum which was not treated with chloroform.  In 
the case of the animal sera, a marked drop in inhibitor levels is seen, comparable 
to the drop in human sera, but no significant amount of proteolytic activity 
appears.  Apparently the  animal  sera  tested  did  not  contain  a  protease 
analogous  to plasminogen,  since only very low levels of proteolytic activity 
were found either after chloroform treatment or treatment with streptokinase. 
The amount of proteolytic activity found was sufficient to cause lysis of fibrin 
clots,  but  not enough  to  produce  significant  hydrolysis of  gelatin under 
the conditions employed. 
DISCUSSION 
The activation of plasminogen  which  occurs  when  serum is shaken with 
chloroform does not appear to be due to a direct action of chloroform on the 
enzyme.  The observations  supporting this view are as follows: First, it is 
likely that if chloroform acted directly on plasminogen to convert it to plasmin, 
activation would  begin  immediately or  shortly after chloroform  treatment. 
This is not the case, but rather there is a period of several days before demon- 
strable  activation  occurs.  Second,  one  might  expect  that  the  activation 
curve would  resemble that of a first order reaction,  rather than that of an 
autocatalytic reaction. 
It appears that the spontaneous activation of plasminogen is associated with 
the marked decrease in the concentration of serum inhibitor.  Previous investi- 
gators have shown that crystalline trypsin inhibitor may be bound to serum 
proteins (Grob,  1943), and Teale and Bach  (1920) have shown that serum 
inhibitor is inactivated by chemical  reagents only when  coagulation of the 
serum proteins occurs.  It is probable,  therefore,  that the denaturation of 
serum proteins occurring when serum is treated with chloroform is responsible 
for the  rapid  loss  of inhibitor.  It has  also  been  shown  (Christensen  and 
MacLeod, 1945) that serum inhibitor, which is much less active against plasm~n 
than against trypsin, does produce inhibition of plasmin.  These facts suggest 
that removal of serum inhibitor is essential for spontaneous activation of plas- 
minogen, and that this removal is brought about by treatment with chloroform. 
In agreement with this hypothesis is the earlier observation (Chrlstensen  and 
MacLeod, 1945) that serum fractions containing plasminogen  will activate 
spontaneously in the refrigerator in the absence  of chloroform  when the in- 
hibitor content of the fraction is low.  H the inhibitor content of the fraction is 
high, spontaneous activation is delayed or prevented entirely. 
It  appears,  therefore,  that the  spontaneous activation of plasminogen  is 
analogous  to the spontaneous activation of trypsinogen.  Crude trypsinogen 
preparations which contain inhibitor do not activate spontaneously (Kuuitz 
and Northrop, 1935).  However, when the inhibitor is removed, the trypsinogen 
is rapidly and autocatalyticaUy  converted to trypsin.  The autoinactivation  of 
plasmin and plasminogen  in solutions containing free plasmin has prevented I~  R.  CHRISTENSEN  157 
establishment of the exact nature of the spontaneous activation of plasminogen, 
and while the present experiments do not remove the possibility of the reaction 
of chloroform with a precursor, which in turn activates plasminogen, it does not 
appear unreasonable to suppose that the activation is autocatalytic. 
SUMT~'A]ty AND CONCLUSIONS 
1.  Treatment of serum with chloroform results in immediate inactivation of 
the protease inhibitor present. 
2.  Following a lag period of less than one to several days, proteolytic activity 
begins to  appear  in the  chloroform-treated serum.  Activity increases over 
a period of several days and then begins to diminish gradually.  At about the 
time when the spontaneous activity begins to diminish, the total proteolytic 
activity of the preparation  also  begins  to fall  until finally the  two curves 
coincide. 
3.  Chloroform treatment of serum appears to result in some destruction of 
plasminogen because not only is the total proteolytic activity of the chloroform- 
treated serum less than that of the serum before chloroform treatment, but the 
maximum spontaneous activity that develops is only about one-half the total 
proteolytic activity of serum before treatment with chloroform. 
4.  The spontaneous activation of plasminogen which occurs following re- 
moval of inhibitor appears to be autocatalytic in nature. 
5.  In the presence  of active plasmin, both  plasmin  and plasminogen are 
destroyed. 
The author takes pleasure  in acknowledging the assistance  of Mrs. J. Fuld. 
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